In regard to EGFR/PTEN/mTOR-pathway alterations, the literature consistently reports mTOR to be active in cervical cancer and to be a key pathway modulating HPV-associated cell signaling alterations [10]. The gene discussed is MTOR; the disease is cervical carcinoma.